Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based Study

BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists are a relatively recent addition to the treatment options for type 2 diabetes mellitus (T2DM) and are administered using prefilled pen devices. METHOD: In this open-label task and interview-based pilot study, 3 GLP-1 receptor agonist pen...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Diabetes Sci Technol
Asıl Yazarlar: Stauder, Udo, Enginee, Diplom, Elton, Hina, Penfornis, Alfred, Edelman, Steve
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2014
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454110/
https://ncbi.nlm.nih.gov/pubmed/24876548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296813511733
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller